Genetic analysis of DNA excreted in urine: A new approach for detecting specific genomic DNA sequences from cells dying in an organism

Clinical Chemistry

Volumn 46, Issue 8 I, 2000, Pages 1078-1084

  Botezatu, I ^a   Serdyuk, O ^a   Potapova, G ^a   Shelepov, V ^a   Alechina, R ^a   Molyaka, Y ^a   Anan'ev, V ^a   Bazin, I ^a   Garin, A ^a   Narimanov, M ^a   Knysh, V ^a   Melkonyan, H ^a   Umansky, S ^a   Lichtenstein, A ^a  

^a DIAGEN Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; POLYMER;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; KIDNEY CLEARANCE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RADIOACTIVITY; URINALYSIS;

ANIMALIA; RODENTIA;

EID: 0033870263     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.8.1078     Document Type: Article

References (28)

1. Plasma DNA as cell death marker in elderly patients
2. Free DNA in the serum of cancer patients and the effect of therapy
3. Extracellular DNA in blood and urine as a potential marker for cytotoxicity and nephrotoxicity in the mouse
4. Simple procedure of DNA isolation from human serum
5. Microsatellite alterations in plasma DNA of small cell lung cancer patients
6. Microsatellite alterations in serum DNA of head and neck cancer patients
7. Detection of tumor DNA in serum of colorectal cancer patients
8. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
9. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features
10. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia
11. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma
12. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
13. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
14. Presence of fetal DNA in maternal plasma and serum
15. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
16. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma
17. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR
18. Fetal RhD genotyping from maternal plasma
19. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients
20. Molecular cloning
21. Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR
22. Improved DNA typing of human urine by adding EDTA
23. A human Y-chromosome specific repeated DNA family (DYZ1) consists of a tandem array of pentanucleotides
24. A simple, rapid, and sensitive DNA assay procedure
25. Rapid clearance of fetal DNA from maternal plasma
26. Passive entry of a DNA molecule into a small pore
27. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: Urinary DNA chimerism